Voyageur Pharmaceuticals Ltd.
VM.V
TSX
| 08/31/2024 | 05/31/2024 | 02/29/2024 | 11/30/2023 | 08/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -1.13M | -955.80K | -1.00M | -1.03M | -1.25M |
| Total Depreciation and Amortization | 1.30K | 1.40K | 1.50K | 1.60K | 6.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 332.40K | 283.90K | 279.40K | 205.20K | 281.00K |
| Change in Net Operating Assets | 530.10K | 354.10K | 189.60K | 80.60K | 62.50K |
| Cash from Operations | -261.60K | -316.40K | -530.60K | -745.80K | -902.80K |
| Capital Expenditure | -120.40K | -121.30K | -126.40K | -129.60K | -139.70K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | 6.50K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -120.40K | -121.30K | -126.40K | -129.60K | -133.20K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -8.80K |
| Issuance of Common Stock | 499.20K | 510.00K | 510.00K | 1.22M | 1.22M |
| Repurchase of Common Stock | -18.10K | -18.10K | -16.40K | -16.40K | -8.10K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 37.80K | -12.50K | -8.90K | -47.10K | -63.50K |
| Cash from Financing | 385.50K | 357.00K | 360.90K | 854.70K | 842.30K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash | 3.40K | -80.90K | -296.30K | -20.80K | -193.70K |
